Diabetes Mellitus affects 346 million people and is one of the leading causes of death worldwide.
Serious complications caused by diabetes include:
- Organ damage including damage to the heart, kidneys, eyes, blood vessels and nerves
- Heart attack and/or stroke
- Neuropathy including, foot ulcers, infection and limb amputation
- Kidney failure
As if this is not bad enough, researchers at the George Institute for Global Health evaluated approximately 20 million people around the world and found that those living with type 1 or type 2 diabetes have a significantly higher incidence of cancer. For women diagnosed with diabetes, the risk of developing some form of cancer is 27 percent higher than women without diabetes and for men suffering from diabetes the risk is 19 percent higher.
The specific cause is not completely clear, but researchers theorize that elevated levels of blood glucose may cause DNA damage that contributes to the genetic mutations that cause cancer. Stem cell therapy may decrease hyperglycemia (high blood sugar) and the complications associated with hyperglycemia.
Stem cells are a type of undifferentiated cell that are able to differentiate into specialized cell types. Stem cells can be guided into becoming a specific type of cell allowing physicians trained in the field of regenerative medicine to use stem cells to repair diseased or damage tissue.
Stem cell therapies offered at the Stem Cells Transplant Institute may improve the symptoms and signs of diabetes mellitus including:
- Excessive thirst
- Frequent Urination
- Excessive hunger or increased appetite
- Blurred Vision
At the Stem Cells Transplant Institute, we use adult autologous stem cells for the treatment of diabetes mellitus. Researchers have shown mesenchymal stem cells have the potential to treat many chronic diseases, including diabetes. Mesenchymal stem cells have the ability to differentiate, self-renew, suppress the immune system, reduce inflammation, and repair tissues and are considered an ideal candidate for the treatment of diabetes. Contact us today to learn more about stem cell therapy.
Ohkuma T., et al., Sex differences in the association between diabetes and cancer: a systemic review and meta-analysis of 121 cohorts including 20 million individuals and one million events. Diabetologia 2018 Jul 20.